Literature DB >> 27896528

Low-level laser therapy as an adjunct to conventional therapy in the treatment of diabetic foot ulcers.

R K Mathur1, Khageswar Sahu2, Siddharth Saraf3, Pooja Patheja4, Fareed Khan1, P K Gupta4.   

Abstract

Foot ulcers are serious complications of diabetes mellitus (DM) and are known to be resistant to conventional treatment. This study was conducted to evaluate the efficacy of low-level laser therapy (LLLT) for the treatment of diabetic foot ulcers in a tertiary care centre (Department of Surgery, Mahatma Gandhi Memorial Medical College and Maharaja Yashwantrao Hospital, A.B. Road, Indore). A total of 30 patients with type 2 DM having Meggitt-Wagner grade I foot ulcers of more than 6 weeks duration with negative culture were studied. Patients were randomized into two groups of 15 each. Patients in study group received LLLT (660 ± 20 nm, 3 J/cm2) along with conventional therapy and those in control group were treated with conventional therapy alone. The primary outcome measure was the absolute and relative wound size reduction at 2 weeks compared to the baseline parameter. Percentage ulcer area reduction was 37 ± 9% in the LLLT group and 15 ± 5.4% in the control group (p < 0.001). For ∼75% of wounds of the treatment group, wound area reduction of 30-50% was observed. In contrast, for the control group, ∼80% of wounds showed a wound area reduction of <20% on day 15. Further, the wounds with initial wound area 1000-2000 mm2 seems to have better final outcome than the groups with larger areas. The treated groups showed higher amount of granulation than the control group. The results suggest that LLLT is beneficial as an adjunct to conventional therapy in the treatment of diabetic foot ulcers.

Entities:  

Keywords:  Adjuvant therapies; Ankle brachial index (ABI); Diabetic foot ulcers (DFU); Low-level laser therapy (LLLT); Wound healing

Mesh:

Substances:

Year:  2016        PMID: 27896528     DOI: 10.1007/s10103-016-2109-2

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  40 in total

1.  Low intensity laser therapy (LILT) in vivo acts on the neutrophils recruitment and chemokines/cytokines levels in a model of acute pulmonary inflammation induced by aerosol of lipopolysaccharide from Escherichia coli in rat.

Authors:  F Mafra de Lima; A B Villaverde; M A Salgado; H C Castro-Faria-Neto; E Munin; R Albertini; F Aimbire
Journal:  J Photochem Photobiol B       Date:  2010-07-27       Impact factor: 6.252

2.  Low-level laser irradiation, cyclooxygenase-2 (COX-2) expression and necrosis of random skin flaps in rats.

Authors:  Ivaldo Esteves Junior; Igor B Masson; Celina T F Oshima; Ana Paula R Paiotti; Richard E Liebano; Helio Plapler
Journal:  Lasers Med Sci       Date:  2011-10-21       Impact factor: 3.161

Review 3.  The role of growth factors in wound healing.

Authors:  D L Steed
Journal:  Surg Clin North Am       Date:  1997-06       Impact factor: 2.741

4.  Effects of low-power laser irradiation (LPLI) at different wavelengths and doses on oxidative stress and fibrogenesis parameters in an animal model of wound healing.

Authors:  Paulo Cesar Lock Silveira; Luciano A Silva; Tiago P Freitas; Alexandra Latini; Ricardo A Pinho
Journal:  Lasers Med Sci       Date:  2010-09-24       Impact factor: 3.161

5.  [Venous leg ulcers: no improvement of wound healing with 685-nm low level laser therapy. Randomised, placebo-controlled, double-blind study].

Authors:  R Kokol; C Berger; J Haas; D Kopera
Journal:  Hautarzt       Date:  2005-06       Impact factor: 0.751

Review 6.  New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies.

Authors:  R Eldor; I Raz; A Ben Yehuda; A J M Boulton
Journal:  Diabet Med       Date:  2004-11       Impact factor: 4.359

7.  Epidemiology of diabetic foot problems and predictive factors for limb loss.

Authors:  Aziz Nather; Chionh Siok Bee; Chan Yiong Huak; Jocelyn L L Chew; Clarabelle B Lin; Shuhui Neo; Eileen Y Sim
Journal:  J Diabetes Complications       Date:  2008 Mar-Apr       Impact factor: 2.852

8.  Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers-a randomised control trial.

Authors:  Basavaraj M Kajagar; Ashok S Godhi; Archit Pandit; S Khatri
Journal:  Indian J Surg       Date:  2012-04-11       Impact factor: 0.656

9.  Prevention of diabetic foot ulcer.

Authors:  Bijan Iraj; Fariborz Khorvash; Alireza Ebneshahidi; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2013-03

10.  Topical hyperbaric oxygen and low energy laser therapy for chronic diabetic foot ulcers resistant to conventional treatment.

Authors:  Z Landau; A Schattner
Journal:  Yale J Biol Med       Date:  2001 Mar-Apr
View more
  5 in total

1.  Study on mechanism of release oxygen by photo-excited hemoglobin in low-level laser therapy.

Authors:  Yanliang Xu; Yuexia Lin; Simin Gao; Junfeng Shen
Journal:  Lasers Med Sci       Date:  2017-10-25       Impact factor: 3.161

Review 2.  Update on management of diabetic foot ulcers.

Authors:  Estelle Everett; Nestoras Mathioudakis
Journal:  Ann N Y Acad Sci       Date:  2018-01       Impact factor: 5.691

3.  Treatment of diabetic foot ulcers in a frail population with severe co-morbidities using at-home photobiomodulation laser therapy: a double-blind, randomized, sham-controlled pilot clinical study.

Authors:  Amir Haze; Lilach Gavish; Ofer Elishoov; Dorit Shorka; Tamir Tsohar; Yechiel N Gellman; Meir Liebergall
Journal:  Lasers Med Sci       Date:  2021-05-29       Impact factor: 2.555

4.  Auto-Administered Photobiomodulation on Diabetic Leg Ulcers Treatment: A New Way to Manage It?

Authors:  Elisabetta Merigo; Lixin Tan; Zengyi Zhao; Jean-Paul Rocca; Carlo Fornaini
Journal:  Case Rep Med       Date:  2020-05-20

5.  Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan.

Authors:  Bilal Bin Younis; Adeela Shahid; Rozina Arshad; Saima Khurshid; Muhammad Ahmad; Haroon Yousaf
Journal:  BMC Endocr Disord       Date:  2018-08-06       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.